Comparative Assessment of Thickness Changes in 3D-Printed vs. Custom-Made Mouth Guards for Children in Contact Sports
Launched by CAIRO UNIVERSITY · May 24, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the thickness of two types of mouth guards—traditional custom-made ones and 3D-printed ones—changes over time in children who play contact sports. The goal is to see which type of mouth guard is more effective at preventing injuries and to evaluate their overall performance, including how they affect speech, oral functions, and their cost over a year.
To participate, children aged 8 to 14 who are physically active in contact sports can join, but they must be willing to wear the mouth guard regularly and have parental consent. The study will involve about 56 children, and it aims to provide valuable information that could help make mouth guards safer and more effective for young athletes. Importantly, the trial is not yet recruiting participants, so families interested should keep an eye out for future updates.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Athletic children who play contact sports Age ranges between 8-14 years. Compliance: participants must agree to use mouth guard consistently Parental consent Physically fit
- Exclusion Criteria:
- • Athletic children who play contact sports Age ranges between 8-14 years. Compliance: participants must agree to use mouth guard consistently Parental consent Physically fit
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Gihan Mohamed Abuelniel, Doctoral Degree (Professor)
Study Director
Cairo University
Passant Nagi, Master's Degree
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported